STAT3 and hepatocellular carcinoma: STAT3 inhibition by napabucasin suppresses HCC growth, probably by enhancing the “eat me” calreticulin signal, reducing the expression of the “don’t eat me” protein CD47, and triggering immunogenic cell death [37].